Dr. Hébert was born in Montréal in 1974. He studied biotechnology, and obtained his Ph.D. in Cellular and Molecular Biology at Laval University in 2003. He then completed a postdoctoral fellowship in human genetics at the Katholieke Universiteit Leuven in Belgium. In 2009, he was recruited as Assistant Professor at Laval University. Dr. Hébert is currently an Associate Professor in the Department of Psychiatry and Neuroscience at Laval University. He is also a researcher (group leader) in the Neuroscience Unit of the Research Center of the CHU de Québec – Laval University.

Dr. Hébert’s work focuses on the biological and molecular mechanisms that cause neuronal death and dementia. Specifically, his research team studies the role of micro-RNAs in the development, diagnosis, and treatment of neurodegenerative diseases such as Alzheimer’s disease, frontotemporal dementia, and Huntington’s disease. Micro-RNAs are small molecules in the body that are similar to DNA and regulate the level of proteins. Dr. Hébert’s pioneering research has shown that many micro-RNAs are deregulated in patients with Alzheimer’s disease, and other types of dementia. Curiously, a number of these molecules can reproduce the pathological and clinical symptoms of dementia in biological models on their own, such as cultured neurons and mice. Dr. Hébert also uses the postmortem human brain as an indispensable tool for his research.

Recently, his work on a potential treatment for Alzheimer’s disease was presented by Le Soleil, the FM93 radio station, and The Alzheimer’s Society of Canada’s Website.

Dr. Hébert has received various awards, including the Alzheimer’s Society of Saskatchewan’s Young Investigator Grant (2010) and the FRQS Junior Research Scholar Career Award (2011, 2014). He has been a spokesperson for the Alzheimer’s Society of Canada (2011). In addition to his commitment to teaching, he regularly participates in various evaluation committees and conferences. Finally, he helps organize events and promote basic Canadian research on Alzheimer’s disease, and related dementias.

CHUL
2705, boulevard Laurier
T-2-48
Québec, Québec
Canada G1V 4G2
67 entries « 7 of 7 »

Serneels L, Dejaegere T, Craessaerts K, Horre K, Jorissen E, Tousseyn T, Hebert S, Coolen M, Martens G, Zwijsen A, Annaert W, Hartmann D, De Strooper B

Differential contribution of the three Aph1 genes to gamma-secretase activity in vivo.

Journal Article

Proc Natl Acad Sci U S A, 102 (5), pp. 1719-24, 2005, ISSN: 0027-8424.

Abstract | Links:

Hebert SS, Serneels L, Dejaegere T, Horre K, Dabrowski M, Baert V, Annaert W, Hartmann D, De Strooper B

Coordinated and widespread expression of gamma-secretase in vivo: evidence for size and molecular heterogeneity.

Journal Article

Neurobiol Dis, 17 (2), pp. 260-72, 2004, ISSN: 0969-9961.

Abstract | Links:

Hebert SS, Godin C, Levesque G

Oligomerization of human presenilin-1 fragments.

Journal Article

FEBS Lett, 550 (1-3), pp. 30-4, 2003, ISSN: 0014-5793.

Abstract | Links:

Godin C, Auclair A, Ferland M, Hebert SS, Carreau M, Levesque G

Presenilin-1 is indirectly implicated in Notch1 cleavage.

Journal Article

Neuroreport, 14 (12), pp. 1613-6, 2003, ISSN: 0959-4965.

Abstract | Links:

Hebert SS, Bourdages V, Godin C, Ferland M, Carreau M, Levesque G

Presenilin-1 interacts directly with the beta-site amyloid protein precursor cleaving enzyme (BACE1).

Journal Article

Neurobiol Dis, 13 (3), pp. 238-45, 2003, ISSN: 0969-9961.

Abstract | Links:

Hebert SS, Godin C, Tomiyama T, Mori H, Levesque G

Dimerization of presenilin-1 in vivo: suggestion of novel regulatory mechanisms leading to higher order complexes.

Journal Article

Biochem Biophys Res Commun, 301 (1), pp. 119-26, 2003, ISSN: 0006-291X.

Abstract | Links:

Hebert SS, Daviau A, Grondin G, Latreille M, Aubin RA, Blouin R

The mixed lineage kinase DLK is oligomerized by tissue transglutaminase during apoptosis.

Journal Article

J Biol Chem, 275 (42), pp. 32482-90, 2000, ISSN: 0021-9258.

Abstract | Links:

67 entries « 7 of 7 »
Signaler des ajouts ou des modifications